2
Visions PV .014P RX digital IVUS catheter is designed for peripheral use Visions PV .014P RX digital IVUS catheter The Visions PV .014P RX has a 50% stiffer shaft than Eagle Eye Platinum and PV .014P to facilitate greater pushability while preserving the equivalent level of trackability. 1 IVUS provides detailed and accurate assessment of: • Lumen Size • Vessel Size • Plaque morphology • Key anatomical landmarks By providing detailed and accurate measurements of lumen and vessel size, plaque area and the location of key anatomical landmarks, Philips Volcano intravascular ultrasound (IVUS) is a valuable tool in the assessment of peripheral artery disease (PAD). 2,3,4,5,6,7

Visions PV .014P RX digital IVUS catheter · 2014/4/1  · inpatient sample (2006 2011). J Endovasc Ther 2016;23(1):65-75. 8. Kumakura H, Kanai H, Araki Y, Hojo Y, Iwasaki T, Ichikawa

  • Upload
    others

  • View
    2

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Visions PV .014P RX digital IVUS catheter · 2014/4/1  · inpatient sample (2006 2011). J Endovasc Ther 2016;23(1):65-75. 8. Kumakura H, Kanai H, Araki Y, Hojo Y, Iwasaki T, Ichikawa

Visions PV .014P RX digital IVUS catheteris designed for peripheral use

Visions PV .014P

RX digital IVUS

catheter

The Visions PV .014P RX has a 50% stiffer shaft than Eagle Eye Platinum and PV .014P to facilitate greater pushability while preserving the equivalent level of trackability.1

IVUS provides detailed and accurate assessment of:• Lumen Size• Vessel Size• Plaque morphology• Key anatomical landmarks

By providing detailed and accurate measurements of lumen and vessel size, plaque area and the location of key anatomical landmarks, Philips Volcano intravascular ultrasound (IVUS) is a valuable tool in the assessment of peripheral artery disease (PAD).2,3,4,5,6,7

Page 2: Visions PV .014P RX digital IVUS catheter · 2014/4/1  · inpatient sample (2006 2011). J Endovasc Ther 2016;23(1):65-75. 8. Kumakura H, Kanai H, Araki Y, Hojo Y, Iwasaki T, Ichikawa

© 2017 Koninklijke Philips N.V. All rights reserved.Trademarks are the property of Koninklijke PhilipsN.V. or their respective owners.600-0500.29/LB

Philips Volcano3721 Valley Centre Drive, Suite 500San Diego, CA 92130 USAwww.volcanocorp.com

1. N=15 Data on File at Volcano Corporation.

2. Kashyap VS, Pavkov ML, Bishop PD, Nassoiy SP, Eagleton MJ, Clair DG, Ouriel K. Angiography underestimates peripheral atherosclerosis: lumenography revisited. J Endovasc Ther 2008;15(1):117-25.

3. Iida O, Takahara M, Soga Y, Suzuki K, Hirano K, Kawasaki D, Shintani Y, Suematsu N, Yamaoka T, Nanto S, Uematsu M. Efficacy of intravascular ultrasound in femoropopliteal stenting for peripheral artery disease with TASC II class A to C lesions. J Endovasc Ther 2014;21(4):485-92.

4. Hitchner E, Zayed M, Varu V, Lee G, Aalami O, Zhou W. A prospective evaluation of using IVUS during percutaneous superficial femoral artery interventions. Ann Vasc Surg 2015;29(1):28-33.

5. Lee JT, Fang TD, White RA. Application of intravascular ultrasound in the treatment of peripheral occlusive disease. Semin Vasc Surg 2006;19(3):139-44.

6. Arthurs ZM, Bishop PD, Feiten LE, Eagleton MJ, Clair DG, Kashyap VS. Evaluation of peripheral atherosclerosis: a comparative analysis of angiography and intravascular ultrasound imaging. J Vasc Surg 2010;51(4):933-8.

7. Panaich SS, Arora S, Patel N, Patel NJ, Savani C, Patel A, Thakkar B, Singh V, Patel S, Patel N, Agnihotri K, Bhatt P, Deshmukh A, Gupta V, Attaran RR, Mena CI, Grines CL, Cleman M, Forrest JK, Badheka AO. Intravascular ultrasound in lower extremity peripheral vascular interventions: variation in utilization and impact on in-hospital outcomes from the nationwide inpatient sample (2006 2011). J Endovasc Ther 2016;23(1):65-75.

8. Kumakura H, Kanai H, Araki Y, Hojo Y, Iwasaki T, Ichikawa S. Fifteen-year patency and life expectancy after primary stenting guided by intravascular ultrasound for iliac artery lesions in peripheral arterial disease. JACC Cardiovasc Interv 2015;8(14):1893-901.

When comparing the stiffness of the Visions PV .014P RX to that of the Eagle Eye Platinum control and the Visions PV .018, the data demonstrated that Visions PV .014P RX is 55% stiffer than the Eagle Eye Platinum and is statistically equivalent to that of Visions PV .018.1

99.6%

Average compression force Visions PV .014P RX % stiffness to control and Visions PV .018

4

3.5

03

2.5

2

1.5

1

0.5

0Average Compression Force (Ibf) % Stiffness of Control

155.2%

0 0

155.8%

% Stiffness of PV .018

Visions PV .014P RXVisions PV .018Eagle Eye Platinum control

64.2%

Visions PV .014P RXVisions PV .018Average Eagle Eye Platinum control

3.563 3.578

2.296

More force is required to buckle PV .014P RX

Ordering information and technical specification

PIM connector

Brachial and femoralshaft markers

Guide wireexit port≤ 0.014" (0.36 mm)

Transducer3.5 F

Tapered tipO.D. 0.019”

150 cm

3.3 F

100 cm

24 cm hydrophilic coating

Visions PV .014P RX digital IVUS catheter 014R

Min sheath: 5FMin guide catheter: 5F (I.D. ≥ .056")